The "Angioedema Epidemiology Forecast to 2032" report has been added to ResearchAndMarkets.com's offering.
This "Angioedema Epidemiology Forecast to 2032" report delivers an in-depth understanding of the disease, historical and forecasted Angioedema epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Geographies Covered
- The United States
- EU5 (Germany, France, Italy, Spain, and the United Kingdom)
- Japan
Study Period: 2019-2032
Angioedema Understanding
The Angioedema epidemiology report gives a thorough understanding of Angioedema by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Angioedema in the US, Europe, and Japan. The report covers the detailed information of the Angioedema epidemiology scenario in seven major countries (US, EU5, and Japan).
Angioedema Epidemiology Perspective
The Angioedema epidemiology division provides insights about historical and current patient pool and forecasted trends for all seven major countries. The Angioedema epidemiology data are studied through all possible divisions to give a better understanding of the disease scenario in 7MM. The Angioedema epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2019 to 2032. It also helps recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.
Angioedema Detailed Epidemiology Segmentation
The Angioedema epidemiology covered in the report provides historical as well as forecasted Angioedema epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2019 to 2032.
The Angioedema report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.
Scope of the Report
- The Angioedema report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
- The Angioedema Epidemiology Report and Model provide an overview of the global trends of Angioedema in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
- The report provides insight into the historical and forecasted patient pool of Angioedema in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
- The report helps recognize the growth opportunities in the 7MM for the patient population
- The report assesses the disease risk and burden and highlights the unmet needs of Angioedema
- The report provides the segmentation of the Angioedema epidemiology
Report Highlights
- 11-year Forecast of Angioedema epidemiology
- 7MM Coverage
- Prevalent and Diagnosed Cases of Angioedema
- Cases of Angioedema by Mutation Types
- Angioedema Cases associated with Clinical Manifestations
Reasons to Buy
The Angioedema Epidemiology report will allow the user to
- Develop business strategies by understanding the trends shaping and driving the global Angioedema market
- Quantify patient populations in the global Angioedema market to improve product design, pricing, and launch plans
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Angioedema therapeutics in each of the markets covered
- Understand the magnitude of Angioedema population by its epidemiology
- The Angioedema Epidemiology Model developed by the publisher is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources
Key Assessments
- Patient Segmentation
- Disease Risk Burden
- Risk of disease by the segmentation
- Factors driving growth in a specific patient population
Key Topics Covered:
1. Key Insights
2. Executive Summary of Angioedema
3. Angioedema: Disease Background and Overview
3.1. Introduction
3.2. Sign and Symptoms
3.3. Pathophysiology
3.4. Risk Factors
3.5. Diagnosis
4. Patient Journey
5. Epidemiology and Patient Population
5.1. Epidemiology Key Findings
5.2. Assumptions and Rationale: 7MM
5.3. Epidemiology Scenario: 7MM
5.3.1. Angioedema Epidemiology Scenario in the 7MM (2019- 2032)
5.4. United States Epidemiology
5.4.1. Angioedema Epidemiology Scenario in the United States (2019- 2032)
5.5. EU-5 Country-wise Epidemiology
5.5.1. Germany Epidemiology
5.5.1.1. Angioedema Epidemiology Scenario in Germany (2019- 2032)
5.5.2. France Epidemiology
5.5.2.1. Angioedema Epidemiology Scenario in France (2019- 2032)
5.5.3. Italy Epidemiology
5.5.3.1. Angioedema Epidemiology Scenario in Italy (2019- 2032)
5.5.4. Spain Epidemiology
5.5.4.1. Angioedema Epidemiology Scenario in Spain (2019- 2032)
5.5.5. United Kingdom Epidemiology
5.5.5.1. Angioedema Epidemiology Scenario in the United Kingdom (2019-2032)
5.6. Japan Epidemiology
5.6.1. Angioedema Epidemiology Scenario in Japan (2019- 2032)
6. Treatment Algorithm, Current Treatment, and Medical Practices
6.1. Angioedema Treatment and Management
6.2. Angioedema Treatment Algorithm
7. KOL Views
8. Unmet Needs
9. Appendix
9.1. Bibliography
9.2. Report Methodology
10. Publisher Capabilities
11. Disclaimer
12. About the Publisher
For more information about this report visit https://www.researchandmarkets.com/r/nxpeij
View source version on businesswire.com: https://www.businesswire.com/news/home/20220728005850/en/
Contacts:
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
